Name | APTEKA N110, OOO |
|---|
INN | 6129006465 |
|---|
KPP | 612901001 |
|---|
OGRN | 1106179000102 |
|---|
OKPO | 2823869 |
|---|
Address | 347483, ROSTOVSKAYA OBLAST', Pervomayskoe, ul. Bogdanova, zd. 58 |
|---|
Phone | 3-14-10 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 46.46 | Additional activity | Wholesale of pharmaceutical goods |
Registration date | 30.06.2010 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 9 po Rostovskoy oblasti |
|---|
|
APTEKA N110, OOO (Rostov Oblast; INN 6129006465) was registered on 30 Jun 2010. The company's authorized capital as of July 1, 2012 was 200058 rub. Principal activities of APTEKA N110, OOO: retailing drugs in specialized stores (pharmacies) (47.73), wholesale of pharmaceutical goods (46.46). |
Economic indicators2023
Net profit (RAS) of APTEKA N110, OOO dropped in 2023 2.19 times to 1.17 million RUB from 2.57 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 11.32% to 14.14 million RUB from 15.95 million RUB in 2022; cost of goods sold decreased by 5.97% to 11.51 million RUB from 12.24 million RUB; sales profit fell 2.09 times to 1.30 million RUB from 2.72 million RUB. 2022
Net profit (RAS) of APTEKA N110, OOO dropped in 2022 by 2.17% to 2.57 million RUB from 2.63 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 36.29% to 15.95 million RUB from 25.03 million RUB in 2021; cost of goods sold decreased by 38.14% to 12.24 million RUB from 19.79 million RUB; sales profit fell by 0.55% to 2.72 million RUB from 2.73 million RUB. 2021
Net profit (RAS) of APTEKA N110, OOO grew over 2021 by 11.54% to 2.63 million RUB from 2.36 million RUB over 2020, the company informed. Revenue increased in the accounting period by 9.37% to 25.03 million RUB from 22.89 million RUB over 2020; cost of goods sold grew by 11.67% to 19.79 million RUB from 17.72 million RUB; sales profit went up by 8.16% to 2.73 million RUB from 2.53 million RUB. 2020
Net profit (RAS) of APTEKA N110, OOO grew over 2020 1.54 times to 2.43 million RUB from 1.58 million RUB over 2019, the company informed. Revenue increased in the accounting period by 41.10% to 22.89 million RUB from 16.22 million RUB over 2019; cost of goods sold grew by 46.48% to 17.72 million RUB from 12.10 million RUB; sales profit went up 1.53 times to 2.53 million RUB from 1.65 million RUB. 2019
Net profit (RAS) of APTEKA N110, OOO grew over 2019 by 10.50% to 1.58 million RUB from 1.43 million RUB over 2018, the company informed. Revenue increased in the accounting period by 17.86% to 16.22 million RUB from 13.76 million RUB over 2018; cost of goods sold grew by 23.44% to 12.10 million RUB from 9.80 million RUB; sales profit went up by 8.33% to 1.65 million RUB from 1.52 million RUB. 2018
Net profit (RAS) of APTEKA N110, OOO dropped in 2018 by 0.58% to 1.37 million RUB from 1.38 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 5.58% to 13.76 million RUB from 13.04 million RUB over 2017; cost of goods sold grew by 6.17% to 9.80 million RUB from 9.23 million RUB; sales profit went up by 0.73% to 1.52 million RUB from 1.51 million RUB. 2017
Net profit (RAS) of APTEKA N110, OOO dropped in 2017 by 18.49% to 1.38 million RUB from 1.69 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 2.11% to 13.04 million RUB from 13.32 million RUB in 2016; cost of goods sold decreased by 3.82% to 9.23 million RUB from 9.60 million RUB; sales profit fell by 16.78% to 1.51 million RUB from 1.82 million RUB. 2016
Net profit (RAS) of APTEKA N110, OOO grew over 2016 by 6.34% to 1.69 million RUB from 1.59 million RUB over 2015, the company informed. Revenue decreased in the accounting period by 6.95% to 13.32 million RUB from 14.31 million RUB in 2015; cost of goods sold decreased by 8.93% to 9.60 million RUB from 10.54 million RUB; sales profit went up by 6.13% to 1.82 million RUB from 1.71 million RUB. 2014
Net profit (RAS) of APTEKA N 110, OOO grew over 2014 by 12.91% to 1.39 million RUB from 1.23 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 27.06% to 11.23 million RUB from 15.40 million RUB in 2013; cost of goods sold decreased by 32.40% to 8.03 million RUB from 11.88 million RUB; sales profit went up by 12.11% to 1.49 million RUB from 1.33 million RUB. 2013
Net profit (RAS) of APTEKA N 110, OOO grew over 2013 1.70 times to 1.23 million RUB from 725.00 thousand RUB over 2012, the company informed. Revenue decreased in the accounting period by 20.56% to 15.40 million RUB from 19.38 million RUB in 2012; cost of goods sold decreased by 16.93% to 11.88 million RUB from 14.30 million RUB; sales profit went up 1.61 times to 1.33 million RUB from 828.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|